About GeoVax Labs Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.geovax.com/
Frequently Asked Questions
What is the 52-week range for GOVX?
The 52-week high is $15.75 and the 52-week low is $0.32.
What is the P/E ratio for GOVX?
The P/E ratio data is currently unavailable.
What is the dividend yield for GOVX?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -743.66%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -403.80%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 1.34.
Analyst Recommendation Trends
Wall Street analyst consensus for GOVX over the last few months:
Latest GOVX News
GeoVax Highlights Likely Sustained Clade Ib Mpox Transmission in the United States
CDC Reports Changing U.S. Transmission Dynamics Underscore Importance of Continued Surveillance, Vaccine Preparedness and Resilient MVA Vaccine Supply ATLANTA, GA - September 29, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stag...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 90.6% to $3.87 during Wednesday's after-market session. The market value of their outstanding shares is at $1.7 million. Greenland Mines (NASDAQ:GRML) shares
GeoVax Next-Generation MVA Vaccine Demonstrates Durable Single-Dose Protection in Preclinical Models
Study Shows Protection Against Highly Pathogenic Clade I Mpox Virus and Durable CD8+ T-Cell Responses Findings Support GeoVax's Broader Strategy to Expand the Utility of the MVA Vaccine Platform ATLANTA, GA - September 21, 2026 (NEWMEDIAWIRE) - GeoVa...
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 12.9% to $4.24 during Friday's after-market session. The market value of their outstanding shares is at $14.8 million. Geovax Labs (NASDAQ:GOVX) stock rose
GeoVax Confirms Bundibugyo Ebola Vaccine Construct
BDBV-Specific Construct Developed Using GeoVax Proprietary Rapid Cloning Technology and Builds on Established Filovirus Vaccine Experience GEO-MVA (Mpox/Smallpox Vaccine) Targeted for Phase 3 Initiation Remains Company Priority ATLANTA, GA - Septembe...
Noble Capital Markets Maintains Outperform on Geovax Labs, Maintains $10 Price Target
Noble Capital Markets analyst Robert LeBoyer maintains Geovax Labs (NASDAQ:GOVX) with a Outperform and maintains $10 price target.
GeoVax and CEPI Enter Agreement to Utilize CEPI Centralised Laboratory Network to Support GEO-MVA Phase 3 Trial
Independent Evaluation Supports GEO-MVA Pivotal Phase 3 Program Advances GeoVax's Strategy to Expand and Diversify MVA Vaccine Supply ATLANTA, GA - September 14, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology c...
GeoVax Provides Nasdaq Listing Update and Reaffirms Focus on Advancing Strategic Priorities
ATLANTA, GA - September 10, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies against high-consequence infectious diseases and solid tumor cancers, today provided an...
GeoVax Welcomes Launch of Global Mpox Vaccine Stockpile, Highlights GEO-MVA Readiness to Support Diversified Global Supply
Gavi-funded, ICG-Coordinated Initiative Establishes Long-Term Infrastructure for Timely and Equitable Mpox Vaccine Access During Outbreaks New Stockpile Framework Supports Sustainable Supply and Long-Term Global Preparedness ATLANTA, GA - September 9...
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-06-17 | Morgan Jayne | +6,000 | - | - |
| 2026-06-17 | Lemerond Nicole | +6,000 | - | - |
| 2026-06-17 | McKee Kelly T. Jr. | +17,600 | - | - |
| 2026-06-17 | Sharkey John W. | +17,600 | - | - |
| 2026-06-17 | Kollintzas Dean G | +6,000 | - | - |
| 2026-06-17 | Reynolds Mark | +17,600 | - | - |
| 2026-06-17 | SPENCER JOHN N JR | +6,000 | - | - |
| 2026-06-17 | NEWMAN MARK J | +17,600 | - | - |
| 2026-06-17 | DODD DAVID A | +29,300 | - | - |
| 2026-06-17 | CHASE RANDAL D | +6,000 | - | - |
| 2026-06-17 | MCNALLY ROBERT T | +6,000 | - | - |
| 2025-10-17 | SPENCER JOHN N JR | +10,000 | $0.5498 | $5,498 |